الدليل الوطني للأدوية المسجّلة في لبنان
تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان
يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم
الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| J01FA09 | RITHROCID | G | Clarithromycin - 500mg | 500mg | Tablet, film coated | 686703.5175 |
| J01FA09 | KLACID | B | Clarithromycin - 500mg | 500mg | Injectable powder for solution | 1428504.5775 |
| J01FA09 | KLACID | B | Clarithromycin - 125mg/5ml | 125mg/5ml | Granules for suspension | 575164.59 |
| J01FA09 | CLARIDAR DAR AL DAWA | G | Clarithromycin - 125mg/5ml | 125mg/5ml | Suspension | 295645.35 |
| J01FA09 | KLACID | B | Clarithromycin - 250mg/5ml | 250mg/5ml | Granules for suspension | 1698616.92 |
| J01FA09 | CLARIDAR DAR AL DAWA | G | Clarithromycin - 250mg/5ml | 250mg/5ml | Suspension | 877529.1525 |
| J01FA09 | KLACID RM | B | Clarithromycin - 500mg | 500mg | Tablet, modified release | 1173174.5025 |
| J01FA02 | ROVAMYCINE | B | Spiramycin - 3MIU | 3MIU | Tablet, film coated | 649075.9275 |
| J01FA02 | ROVAMYCINE | B | Spiramycin - 1.5MIU | 1.5MIU | Tablet, film coated | 256673.9175 |
| J01EE01 | PAEDIATRIC CO-TRIMOXAZOLE MIXTURE | G | Trimethoprim - 40mg/5ml, Sulfamethoxazole - 200mg/5ml | Suspension | 190697.65 | |
| J01EE01 | BACTRIM FORTE | B | Trimethoprim - 160mg, Sulfamethoxazole - 800mg | Tablet | 344023.68 | |
| J01EE01 | CO-TRIMOXAZOLE | G | Trimethoprim - 160mg, Sulfamethoxazole - 800mg | Tablet | 7529090.0345 | |
| J01EE01 | CO-TRIMOXAZOLE | G | Trimethoprim - 160mg, Sulfamethoxazole - 800mg | Tablet | 183018.55 | |
| J01DI54 | ZERBAXA | B | Ceftolozane Sulfate - 1g, Tazobactam (sodium) - 0.5g | Injectable powder for concentrate for solution | 74780802.422812 | |
| J01DI02 | ZINFORO | G | Ceftaroline fosamil - 600mg | 600mg | Injectable powder for concentrate for solution | 44995861.512 |
| J01DI01 | ZEVTERA | B | Ceftobiprole medocaril Sodium - 500mg | 500mg | Injectable powder for concentrate for solution | 47129773.02201 |
Download the new version of the MOPH app
for the latest updates on Coronavirus.
The new version of the MOPH APP will provide you with all the reliable information on COVID-19 with ongoing update of the confirmed cases and data. If you are showing any symptoms, the “Symptoms Checker” will be your self-help guide to assess them.
